CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


CLIA of IgG and IgM against SARS-Cov-2Wiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)


Name (Synonyms) Correlation

Correlated MeSH Terms (2)


Name (Synonyms) Correlation
D013315 Stress, Psychological NIH 0.21
D001008 Anxiety Disorders NIH 0.17

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Development and Persistence of Humoral Immunity Against SARS-CoV-2 in Liver Transplanted Patients in Comparison With Immunocompetent Patients

This is a prospective study analyzing the development of humoral immune response against SARS-Cov-2 in patients with previous Covid19: the aim is to compare the incidence, titration and evolution of IgG an IgM in a prospective cohort of liver transplant patients surviving to the first wave of Covid19, in comparison to not inmmunossupressed patients.

NCT04410471 Liver Transplant Infection Covid19 Mortality Immune Response Diagnostic Test: CLIA of IgG and IgM against SARS-Cov-2

Primary Outcomes

Description: Proportion, Rate

Measure: Incidence of IgG against SARS-CoV-2

Time: one year

Secondary Outcomes

Description: Titer

Measure: titration and evolution of humoral response (IgG) along first 12 months after having Covid-19

Time: 12 months

Description: Categoric Yes/Not

Measure: Reinfection of Covid-19

Time: one year

Other Outcomes

Description: Rate

Measure: Mortality

Time: 12 months after Covid-19


No related HPO nodes (Using clinical trials)